Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab versus calcitonin for prevention of vertebral refracture after PKP/PVP in postmenopausal women
ChiCTR2400092979Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Nov 2024
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of denosumab and TBRIA in osteoporosis, sponsored by The First Affiliated Hospital of Zhengzhou University. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
denosumabTBRIA
03
Conditions
osteoporosis
Beyond the preview
Go deeper on ChiCTR2400092979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092979.